Tumor Models Boston

Come see our VP of Biology and Pharmacology, Yinfei Yin, PhD speak on our new comprehensive platform for PROTAC evaluation.

The 12th Annual Tumor Models Boston Summit is the only industry-led meeting uniting 200+ industry experts from pharma, biotech, academic KOLs and preclinical CROs to delve into the latest case studies in leveraging PDX models, genetically engineered mouse models, advanced 3D in vitro models and more. Join industry leaders developing teams in preclinical, translational, pharmacology, discovery, pharmacodynamics, toxicity and biology to optimize and implement more translatable oncology models.

Boston, MA

July 23, 2024

July 23-24th 2024

Learn More

Register

Agendas

Schedule a Time to Meet

More Events:

PBSS: Why All These New Modalities?

Event Topics: Many new drug modalities/platforms have appeared in the recent past, Good targets are hard to find and many are considered “undruggable” Diversity of Modalities expands druggable target space Diversity of Modalities increases probability of technical...

PBSS: Preclinical Development and IND Filing for Small Molecules: Nuts, Bolts and Best Practices

38th ACS National Medicinal Chemistry Symposium

The Division of Medicinal Chemistry of the ACS organizes its National Medicinal Chemistry Symposium in even-numbered years since 1948. The Scientific Organizing Committee will arrange a distinguished lineup of speakers. For four days, Seattle will be the setting of a...